14 research outputs found
Non-denaturing electrospray ionisation-mass spectrometry reveals ligand selectivity in histamine-binding protein
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine
Truncated constructs of 64P (64TRPs), a secreted cement protein from salivary glands of the tick Rhipicephalus appendiculatus, provided cross-protection against Rhipicephalus sanguineus and Ixodes ricinus, apparently by targeting antigens in the midgut and salivary glands of adults and nymphs, causing mortality. Tick feeding on 64TRP-immunised animals stimulated local inflammatory immune responses (involving basophils, eosinophils, lymphocytes, mast cells, macrophages and dendritic-like cells) that boosted the immune status of vaccinated animals. The vaccine trial results, and antigenic cross-reactivity of 64TRPs with R. sanguineus, I. ricinus, Amblyomma variegatum and Boophilus microplus, indicate the potential of 64TRPs as a broad-spectrum anti-tick vaccine
Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata
Blood-feeding ticks must control C activation or be damaged by the host inflammatory response. We report the characterization and expression of a novel, relatively small, broad-acting C inhibitory protein (termed OmCI) from the soft tick Ornithodoros moubata. The native 17-kDa nonglycosylated protein inhibits both human and guinea pig classical and alternative C activation pathways. The IC50 values for each pathway were 12 and 27 nM, respectively, in hemolytic assays using human serum diluted 40-fold. The cDNA encodes a protein of 168 aa, including an 18-aa secretion signal sequence that is absent in the mature form. The inhibitor has 46% amino acid identity with moubatin, a platelet aggregation inhibitor also from O. moubata that is an outlying member of the lipocalin family. Native OmCI had no inhibitory effect on the addition of C8 and C9 to preformed C5b-C7 and C5b-C8 to form the membrane attack complex and no effect on the rate of C3a production by the C3 convertase enzymes C4bC2a, C3(H2O)Bb, or C3bBb. Both recombinant and native OmCI abolish production of C5a by human classical (C4bC3bC2a) and alternative (C3bC3bBb) C5 convertases. Addition of excess C5 but not C3 competes away the inhibitory activity of OmCI, indicating that OmCI targets C5 itself rather than inhibiting the C5 convertase C4bC3bC2a itself. Direct binding of OmCI to C5 was demonstrated by Western blotting and gel filtration chromatography using 125I-labeled proteins. OmCI is the first lipocalin family member shown to inhibit C and also the first natural inhibitor that specifically targets the C5 activation step
Arthropod-derived protein EV131 inhibits histamine action and allergic asthma
Histamine is an important mediator of allergic responses. Arthropods express several biologically active proteins in their saliva, which may allow a prolonged blood meal on the host. Proteins identified and expressed include histamine, serotonin, tryptase, and complement binding proteins. We review here data that scavenging of endogenous histamine by the histamine-binding protein EV131 has a profound inhibitory effect on allergic asthma. Aerosol administration of EV131 prevented airway hyperreactivity and abrogated peribronchial inflammation, eosinophil recruitment, mucus hypersecretion, and IL-4 and IL-5 secretion. Saturation with histamine abrogated the inhibitory effect of EV131 on bronchial hyperreactivity. The data suggest that histamine plays a role in allergies and that scavenging of histamine by EV131 may represent a novel therapeutic strategy in the treatment of allergic diseases
An antivector vaccine protects against a lethal vector-borne pathogen
Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. We tested the ability of an anti-tick vaccine derived from a tick cement protein (64TRP) of Rhipicephalus appendiculatus to protect mice against tick-borne encephalitis virus (TBEV) transmitted by infected Ixodes ricinus ticks. The vaccine has a ādual actionā in immunized animals: when infested with ticks, the inflammatory and immune responses first disrupt the skin feeding site, resulting in impaired blood feeding, and then specific anti-64TRP antibodies cross-react with midgut antigenic epitopes, causing rupture of the tick midgut and death of engorged ticks. Three parameters were measured: ātransmission,ā number of uninfected nymphal ticks that became infected when cofeeding with an infected adult female tick; āsupport,ā number of mice supporting virus transmission from the infected tick to cofeeding uninfected nymphs; and āsurvival,ā number of mice that survived infection by tick bite and subsequent challenge by intraperitoneal inoculation of a lethal dose of TBEV. We show that one dose of the 64TRP vaccine protects mice against lethal challenge by infected ticks; control animals developed a fatal viral encephalitis. The protective effect of the 64TRP vaccine was comparable to that of a single dose of a commercial TBEV vaccine, while the transmission-blocking effect of 64TRP was better than that of the antiviral vaccine in reducing the number of animals supporting virus transmission. By contrast, the commercial antitick vaccine (TickGARD) that targets only the tick's midgut showed transmission-blocking activity but was not protective. The 64TRP vaccine demonstrates the potential to control vector-borne disease by interfering with pathogen transmission, apparently by mediating a local cutaneous inflammatory immune response at the tick-feeding sit
Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans
Experimental evidence suggests that C inhibition and more particularly combined inhibition of C and the TLR coreceptor CD14 may be of therapeutic benefit in sepsis and other inflammatory conditions. A barrier to the testing and further development of many inhibitors is that their activity is species specific. Pig is a relevant species for experimental models of human disease, and this study undertakes a comprehensive comparison of the inhibitory efficacy of the C5 inhibitor Ornithodoros moubata C inhibitor (OmCI) in human and porcine whole blood ex vivo models of Escherichia coli-induced sepsis. The effect of OmCI on complement activity in pigs undergoing E. coli sepsis was also examined. Porcine and human serum, and whole blood anticoagulated with lepirudin, was incubated with E. coli and the effect of OmCI investigated. The ex vivo results were virtually identical in pig and human. OmCI completely ablated the activity of all three C pathways at 0.64 Ī¼M. E. coli-induced C activation and expression of CD11b (wCD11R3 in the pig), was abolished ex vivo at 0.32 Ī¼M OmCI. Combining anti-CD14 and OmCI reduced the formation of IL-8 and TNF-Ī± more potently than the single inhibitors. OmCI also efficiently bound E. coli-induced leukotriene B4 in pig and human plasma. In support of our ex vivo findings, in vivo the activity of all C pathways was inhibited at 0.6 mg OmCI/kg pig. In conclusion, OmCI efficiently inhibited pig and human C activation, has accompanying anti-inflammatory effects and is a promising candidate inhibitor for further in vivo studies of sepsis
Bifunctional lipocalin inhibitor of C5 and leukotriene B4 is protective in experimental immune complex alveolitis
OmCI is an ectoparasite derived bifunctional lipocalin that inhibits complement (C) by binding to C5 and also captures the proinflammatory eicosanoid leukotriene B4 (LTB4). We present the crystal structure of recombinant bacterial bOmCI with and without LTB4 at 2.1 Ć
resolution, and test the relative contributions of C5 inhibition and LTB4 binding to amelioration of experimental immune complex acute lung injury alveolitis (IC-ALI). The structure shows why OmCI is able to accommodate LTB4, arachidonic acid (AA) and 12-OH hydroxyeicosatetraenoic acid (HETEs), but not cysteinyl leukotrienes, prostaglandins or thromboxanes. It also reveals that only minor structural changes occur when bOmCI is bound to LTB4 rather than palmitoleic acid (C16H30O2) which is the dominant fatty acid in the binding pocket of recombinant bOmCI. In accord with the minor structural changes and use of opposite faces of OmCI for C5 binding and entry of LTB4, the two activities of the protein appear to be entirely independent - since the binding kinetics to LTB4 do not change when bOmCI is bound to C5 and the affinity for C5 and inhibition of C activation is unaltered by binding LTB4. In a mouse model of IC-ALI OmCI inhibited neutrophil recruitment and microvascular damage, and reduced protein exudation in the bronchoalveolar space. To examine the relative importance of OmCIs independent inhibitory activities in IC-ALI, OmCI was saturated with LTB4. The saturated protein was a less potent inhibitor of lung inflammation, though both LTB4 binding and C inhibition were required for maximum effect. The dual activity of OmCI may have advantages over conventional biotherapeutics, such as monoclonal antibodies, which typically target only single components of the immune syste
Effect of Immunization on Mice Infested with Virus-Infected and -Uninfected Ticks
<p>Comparison of immunization with either 64TRP antigens, a commercial TBEV vaccine, or the commercial anti-tick vaccine (TickGARD) on (A) transmission = % uninfected nymphal ticks that became infected; (B) support = % mice supporting cofeeding virus transmission between an infected adult female tick and uninfected nymphs; and (C) survival = % mice that survived an infected tick bite (only animals surviving subsequent i.p. inoculation with 1,000 PFU TBEV were included in the analyses).</p